SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001047469-13-008264
Filing Date
2013-08-08
Accepted
2013-08-08 17:19:53
Documents
9
Effectiveness Date
2013-08-08

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2216260zs-3asr.htm S-3ASR 194577
2 EX-4.2 a2216260zex-4_2.htm EX-4.2 680815
3 EX-5.1 a2216260zex-5_1.htm EX-5.1 22933
4 EX-12.1 a2216260zex-12_1.htm EX-12.1 56793
5 EX-23.1 a2216260zex-23_1.htm EX-23.1 2476
6 EX-25.1 a2216260zex-25_1.htm EX-25.1 102635
7 G180122KKI001.JPG g180122kki001.jpg GRAPHIC 2426
8 G884921.JPG g884921.jpg GRAPHIC 9989
9 G704831.JPG g704831.jpg GRAPHIC 18540
  Complete submission text file 0001047469-13-008264.txt   1104304
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-190494 | Film No.: 131023196
SIC: 2836 Biological Products, (No Diagnostic Substances)